Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vericel Corp VCEL

Healthcare Biotechnology
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic... see more

Recent & Breaking News (NDAQ:VCEL)

Vericel Reports Second-Quarter 2016 Financial Results

GlobeNewswire August 8, 2016

Vericel to Host Second-Quarter 2016 Earnings Webcast and Conference Call on August 8, 2016

GlobeNewswire August 1, 2016

Vericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

GlobeNewswire July 6, 2016

Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors

GlobeNewswire June 23, 2016

Vericel Reports First-Quarter 2016 Financial Results

GlobeNewswire May 10, 2016

Vericel to Host First-Quarter 2016 Earnings Webcast and Conference Call on May 10, 2016

GlobeNewswire April 27, 2016

Vericel to Present at 15th Annual Needham Healthcare Conference

GlobeNewswire April 8, 2016

Results from Vericel's Positive Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T Presented Today at ACC and Published in The Lancet

GlobeNewswire April 4, 2016

Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors

GlobeNewswire April 1, 2016

Vericel to Host Review of Positive Phase 2b ixCELL-DCM Trial Results Following American College of Cardiology 65th Annual Scientific Sessions

GlobeNewswire March 29, 2016

Vericel Announces Publication of Clinical Trial Rationale and Study Design for the Phase 2b ixCELL-DCM Trial of Ixmyelocel-T in Patients with Heart Failure Due to Ischemic Dilated Cardiomyopathy

GlobeNewswire March 28, 2016

These Companies Could Be On The Verge Of A Breakout - Here's Why!

Accesswire March 14, 2016

Vericel Reports Fourth-Quarter and Year-End 2015 Financial Results

GlobeNewswire March 14, 2016

Top Penny Stocks to Watch, Friday 3/11/2016

Accesswire March 11, 2016

Active Penny Stocks To Watch Today, Thursday 3/10/2016

Accesswire March 10, 2016

Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T in Patients With Heart Failure Due to Ischemic Dilated Cardiomyopathy

GlobeNewswire March 10, 2016

Vericel Enters Into $10 Million Credit Facility and $5 Million Term Loan Agreement With Silicon Valley Bank

GlobeNewswire March 9, 2016

Vericel to Present at 28th Annual ROTH Conference

GlobeNewswire March 8, 2016

Vericel Announces FDA Acceptance for Filing of BLA for MACI for the Treatment of Symptomatic Cartilage Defects in the Knee

GlobeNewswire March 7, 2016

Vericel to Host Fourth-Quarter 2015 Earnings Webcast and Conference Call on March 14, 2016

GlobeNewswire February 26, 2016